Thursday, March 28, 2024
Advertisement
Updated on: January 02, 2021 9:07 IST

Oxford-AstraZeneca COVID-19 vaccine gets recommendation for emergency use

An expert panel on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Friday recommended to grant emergency use authorisation for the Oxford COVID-19 vaccine Covishield, being manufactured by Serum Institute of India, sources said on Friday. The Pune-based Serum Institute of India (SII), the world's largest vaccine manufacturer, has tied up with AstraZeneca to manufacture Covishield.

Latest Videos

Advertisement
Advertisement
Advertisement
Advertisement